Want to join the conversation?
$LLY, the maker of insulin Humalog, said that in 4Q15 it received approval for launching Portrazza, a lung cancer drug, in US. The company terminated basal insulin peglispro, a treatment for type 1 and type 2 diabetes. $LLY expanded its R&D facility in Indianapolis and announced the closure of animal health manufacturing facility in Sligo, Ireland.
$MON shares dip slightly; I wonder this is because of the environmental lawsuit filed by the Washington state against the production of PCBs.
My bet is that $FR will reach $32 in the short term. It’s time it broke the 52-week high and had its fair share of growth.
$WYNN got bruised up by China after its decision to cut withdrawal limit in Macau ATMs. Wynn Resorts shares went down by more than 11%! Well who could have guessed that right?